Glassman Wealth Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Glassman Wealth Services’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,310	Closed	-$18.2K	–	1439
2023 Q4	$18.2K	Buy	1,310 +10	+0.8%	+$134	﹤0.01%	710
2023 Q3	$17.4K	Sell	1,300 -170	-12%	-$2.3K	﹤0.01%	689
2023 Q2	$18.6K	Buy	1,470 +40	+3%	+$467	﹤0.01%	637
2023 Q1	$16.3K	Buy	1,430 +25	+2%	+$270	﹤0.01%	686
2022 Q4	$14.5K	Buy	1,405 +495	+54%	+$5.34K	﹤0.01%	738
2022 Q3	$10K	Buy	910 +315	+53%	+$3.35K	﹤0.01%	799
2022 Q2	$7K	Buy	595 +140	+31%	+$1.52K	﹤0.01%	922
2022 Q1	$5K	Buy	455 +15	+3%	+$170	﹤0.01%	1009
2021 Q4	$6K	Buy	440 +370	+529%	+$4.66K	﹤0.01%	942
2021 Q3	$1K	Buy	+70	New	+$933	﹤0.01%	1440

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Glassman Wealth Services's RDY Position: Q1 2024 in Review

Glassman Wealth Services sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 1,310 shares — an estimated $18.2K sold.

Glassman Wealth Services first reported a position in RDY in Q3 2021 and held it in 10 quarters. The position peaked at $18.6K in Q2 2023. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

Glassman Wealth Services reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 1,310 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $18.2K.
Glassman Wealth Services first reported a position in Dr. Reddy's Laboratories in Q3 2021 and held it in 10 quarters.
Glassman Wealth Services's Dr. Reddy's Laboratories position peaked at $18.6K in Q2 2023.
231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.